Periosteal distraction improves blood flow and regulates inflammatory response to accelerate foot ulcer healing in diabetic rats Authors: Zhaosu Zheng, Haiyang Guo, Songjun Wang, Xiaodong Bai, Zhaohui Song Published: 2025 ABSTRACT AbstractBackgroundDiabetic foot is a prevalent complication of diabetes mellitus. The tibial transverse transport technique was widely use to diabetic foot management. Recently, some clinical studies have applied tibial periosteal distraction (PD) in diabetic foot patients, reporting favorable therapeutic outcomes. However, the mechanisms by which PD facilitates lower limb wound healing in diabetic foot remain poorly understood. Our study aims to create PD rat model to preliminarily explore the underlying therapeutic mechanisms.MethodsWe developed periosteal distraction fixation system. The periosteal distraction in diabetes rat model (male SD rat) was successfully established. The effects of PD on wound healing were researched. HE staining, immunofluorescence staining and western blot were used to investigate the mechanisms.ResultsPD enhanced wound healing by angiogensis and EPCs recruitment through SDF-1/CXCR4 and OPN signaling activation, and through ERK1/2 phosphorylated to accelerate M2 macrophage polarization. Enhanced neovascularization and EPCs recruitment were observed in the PD group with double immune-labelling of CD31 and α-SMA, CD34 and CD133. SDF-1/CXCR4, OPN signaling activation and ERK1/2 phosphorylation were seen in the results of immunofluorescence staining and western blot in PD group. The amount of M2 macrophages was increased and M1 was reduced in the PD group by immunofluorescence staining.ConclusionPD enhanced blood flow and regulated inflammatory response to accelerate diabetes foot ulcer healing.Keywords: Periosteal distraction, Diabetes ulcer, Wound healing Introduction Diabetic foot, a prevalent complication of diabetes mellitus, is characterized by multifactorial etiology, high ulcer recurrence rates, and poor prognosis [1, 2]. Current therapeutic strategies include glycemic control, wound debridement, and pressure offloading, among others [3–5]. In 1989, Ilizarov introduced the principle of “distraction osteogenesis (DO) [6]” which formed the theoretical foundation for the DH theory and the tibial transverse transport technique. Building upon this principle, Qu et al. [7] pioneered the application of Tibial Transverse Transport (TTT) in the treatment of thromboangiitis obliterans in 2001, achieving promising clinical outcomes. Subsequent studies have extended the use of TTT to diabetic foot management, with investigations into its underlying mechanisms such as HIF-1α/SDF-1/CXCR4, OPN and driving inflammatory responses [8–11]. However, this surgical approach-including osteotomy techniques-entails notable limitations, such as significant tissue trauma, procedural complexity, elevated costs, and patient discomfort during bone transport. Previous studies have demonstrated that periosteal distraction osteogenesis stimulates new bone formation in animal models, including the mandible [12] and skull [13] of rabbits. Similarly, research on rat skull models has confirmed the osteogenic potential of periosteal distraction [14, 15]. Recently, some clinical studies [16–18] have applied tibial periosteal distraction (PD) in diabetic foot patients, reporting favorable therapeutic outcomes. Unlike conventional osteotomy-based techniques, PD cancels the osteotomy, offering advantages such as simplified surgical procedures, reduced trauma, and enhanced patient comfort during the distraction phase. Despite these promising findings, the mechanisms by which periosteal distraction facilitates lower limb wound healing in diabetic foot remain poorly understood. This study designed the PD external fixator system and successfully established PD surgery on diabetes rats, then investigated the mechanism of PD on improving blood flow and regulating inflammatory response. Methods Experimental animals and research design All experimental procedures were approved by the Animal Research Ethics Committee of the Third Hospital of Hebei Medical University (Approval No. Z2024-004-2). This study was complied with the Guide for the Care and Use for Laboratory Animals published by the US National Institutes of Health. We have adhered to the ARRIVE guidelines and have included the ARRIVE checklist. Male Sprague–Dawley (SD) rats (8 weeks old, approximately 300 g body weight) were selected. Following a one-week acclimatization period, the animals were fasted for 12 h prior to diabetes induction. Diabetes was induced by a single intraperitoneal injection of streptozotocin (STZ, pH 4.3, 50 mg/kg), the reagent was freshly prepared before use. Fasting blood glucose levels were measured via tail vein sampling 72 h post-injection. Rats exhibiting blood glucose levels ≥ 16.7 mmol/L were considered diabetic and included in subsequent experiments (About 10% of rats died after STZ injection, so excluding the experiment). Set humane endpoints for diabetes rats (euthanasia is required if blood glucose > 33.3 mmol/L lasts for 48 h). The sample size was considered based on our preliminary experiment, where we compared the wound healing rate and the success rate of diabetes model construction in three groups. Using power calculation with a 90% probability, we decided the sample size as 6 rats per group per analysis. All rats were randomized into 3 groups by simple randomization, with 6 rats per group: (1) Control group (rats were given a sham surgery without fixator implanted); (2) Sham PD group (rats received PD fixator implantation surgery without subsequent distraction); (3) PD group (rats received PD fixator implantation surgery and got subsequent distraction). To minimize potential confounders, all rats received surgery, bedding changes at the same time, and all experimental animals were maintained under strictly controlled conditions to minimize environmental variability: Temperature: 20–26 °C; Humidity: 55 ± 5%; Light cycle: 12/12-h light/dark (lights on 07:00–19:00); Air changes: 15/hour HEPA-filtered; Noise: ≤ 60 dB; Bedding changes: Three times weekly; Environmental enrichment: Sterilized nesting material provided; Cage density: Maximum 2 rats/cage. Construction of periosteal distraction model Development of periosteal distraction fixation system Based on the structure of the tibial transverse bone transport fixation frame used clinically, our team developed the micro periosteal distraction fixation frame, and folded a steel needle with a diameter of 1 mm into a U-shaped ring for the distracting periosteum (Fig. 1A). Introduction of Periosteal distraction (PD) external fixator system, PD surgery and therapeutic procedure. A PD external fixator system and U-shaped ring. B PD surgical procedure: (1) and (2) A 5-mm long skin incision was made perpendicular to the limb’s long axis, followed by layered soft tissue dissection to expose the bone surface; (3), (4) and (5) the periosteum was gently separated from the bone over a 5-mm segment and a second incision was then made at the distal termination point of the separated periosteal segment; (6) the U-shaped ring was then implanted through the two periosteum incisions and connected to the external fixation frame. C Therapeutic procedure of PD. Radiographic Monitoring of U-Shaped Ring Positioning Periosteal distraction surgery Rats were anesthetized using inhaled isoflurane (3% for induction, 2% for maintenance) and positioned in lateral recumbency. The surgical site (right anteromedial lower leg) was shaved and disinfected with medical-grade ethanol. Under guidance from the external fixator, an optimal entry point for the steel needle was selected. A 5-mm long skin incision was made perpendicular to the limb’s long axis, followed by layered soft tissue dissection to expose the bone surface. Using a steel needle, the periosteum was gently separated from the bone over a 5-mm segment. A second incision was then made at the distal termination point of the separated periosteal segment. The U-shaped ring was implanted through the two periosteal incisions and connected to the external fixation frame. The frame itself was anchored to the tibia with two 1-mm-diameter steel needles. After wound closure and disinfection, sharp needle ends were trimmed to prevent abdominal injury (Fig. 1B). Periosteal distraction protocol The surgical day was designated as Day 0. Following a 3-day postoperative observation period, the distraction protocol was initiated on Day 3. The periosteum was distracted outward at a rate of 0.25 mm/12 h for 72 h. This was followed by a 3-day consolidation period (Days 6–8). From Day 9, the periosteum was compressed inward at the same rate (0.25 mm/12 h) for 72 h. A final 3-day stabilization period (Days 12–14) completed the 15-day experimental timeline. On Day 15, all animals were sacrificed and collected sample (Fig. 1C). Skin defect model establishment All experimental groups received a standardized 5 × 5 mm full-thickness rectangular skin defect on the left foot (Fig. 2A). Postoperative care included intramuscular penicillin administration (5 IU/kg/day) for 3 consecutive days. Periosteal distraction (PD) technique promoted skin wound recovery. A Preoperative planning and postoperative condition of skin defect; B Representative photographic documentation of wound healing procedure was obtained from a single SD rat across three groups at standardized timepoints (Days 3, 6, 9, 12, and 15 post-operation); Scale bar 2 mm. C In H&E staining, better continuous epidermis was observed in the PD group. Scale bar 100 μm. D Wound area for three groups during Day 3 to Day 15 (PD vs. Con, Day 6, 9 and 15: p < 0.01; Day 12: p < 0.001; PD vs. Sham PD, Day 6: p < 0.01; Day 9, 12 and 15: p < 0.05; ANOVA and Kruskal–Wallis test). Data were measured as means (standard deviations), *p < 0.05, **p < 0.01, ***p < 0.001; n = 6 Wound healing rate quantification Standardized digital photographs of foot wounds were obtained on postoperative days 3, 6, 9, 12, and 15 using a fixed focal length with an included reference scale. The wound area measured on day 3 was designated as the baseline (A0) to account for potential variations in initial defect size during model establishment. where An represents the wound area at each measurement timepoint. HE staining and immunofluorescence staining On day 15, wound tissue specimens were harvested and subjected to comprehensive histological processing. Samples were immediately fixed in 4% formaldehyde and processed through graded ethanol series for dehydration. Following xylene clearing and paraffin embedding, 5-μm-thick serial sections were obtained using a rotary microtome. Sections were subsequently stained with hematoxylin and eosin (H&E) and immunofluorescence staining. The following antibodies were used: Rabbit anti-rat SDF-1 antibody (SDF-1, Abcam;ab25117, 1:100); Rabbit anti-rat CXCR4 antibody (CXCR4, Abcam;ab124824, 1:100); Rabbit anti-rat CD31 antibody (CD31, Abcam;ab222783, 1:100); Mouse anti-rat α-SMA antibody (α-SMA, Abcam;ab7817, 1:100); Rabbit anti-rat iNOS antibody (iNOS, Abcam;ab15323, 1:100); rabbit anti-rat CD206 antibody (CD206, Abcam;ab64693, 1:100); rabbit anti-rat CD34 antibody (CD34, Abcam;ab81289, 1:100); rabbit anti-rat CD133 antibody (CD133, Novus;NB120-16518, 1:100). Western blot On day 15, the left (contralateral surgery) calf muscles were extracted proteins for Western blot (WB) experiments. The following antibodies were used: Rabbit anti-rat SDF-1 antibody (SDF-1,Abcam;ab25117,1:500); Rabbit anti-rat CXCR4 antibody (CXCR4,Cohesionbio;CPA4381,1:200); Rabbit anti-rat OPN antibody (OPN,Cohesionbio;CPA2096,1:1000); Mouse anti-rat ERK1/2 antibody (ERK1/2, Cohesionbio;CPA9158, 1:1000); Rabbit anti-rat pERK1/2 antibody (pERK1/2, Cohesionbio;CPA5891, 1:1000); rabbit anti-rat Histone H3 antibody (Histone H3, Cohesionbio;CPA3483, 1:500); rabbit anti-rat beta-tubulin antibody (beta-tubulin,Cohesionbio;CPA9247, 1:2000). Statistical analysis All rats were included for data analysis. Analyses were done blindly by two independent researchers (HG, XB). Group allocation and randomization was performed by the third independent researcher (SW). Semi-quantitative measurements of immunofluorescence intensity and Western blot band density and quantitative measurement of wound area were performed using ImageJ software (v1.54 g, National Institutes of Health, USA). All statistical analyses and graphical representations were conducted using GraphPad Prism (v10.0.0, GraphPad Software, San Diego, CA, USA). Continuous variables were expressed as mean ± standard deviation after confirming normal distribution using the Shapiro–Wilk test. Intergroup comparisons were performed using one-way analysis of variance (ANOVA) with Tukey’s post hoc test for multiple comparisons and to compare the mean values. If the data did not meet the assumptions of normality and homogeneity of variance, non-parametric methods (Kruskal–Wallis test) were employed. A p value < 0.05 was considered statistically significant. Results PD enhanced wound healing Quantitative analysis revealed significantly improved wound healing rates (n = 6) in the PD group compared to both Sham PD and control groups (PD vs. Con, Day 6, 9 and 15: p < 0.01; Day 12: p < 0.001; PD vs. Sham PD, Day 6: p < 0.01; Day 9, 12 and 15: p < 0.05; ANOVA and Kruskal–Wallis test) (Table 1; Fig. 2B and D). Histological evaluation via H&E staining demonstrated incomplete wound closure in control groups, characterized by: Disorganized tissue architecture; Reduced epidermal thickness; Hemorrhagic crust formation; Marked vascular deficiency (Fig. 2C). Table 1Wound healing rate for three groups during Day 3 to Day 15Day 3Day 6Day 9Day 12Day 15Con10.68 ± 0.040.53 ± 0.030.41 ± 0.030.20 ± 0.03Sham10.61 ± 0.090.46 ± 0.020.31 ± 0.020.17 ± 0.02PD10.46 ± 0.030.33 ± 0.020.16 ± 0.010.08 ± 0.03 Wound healing rate for three groups during Day 3 to Day 15 Angiogenic and EPCs recruitment mechanisms Immunofluorescence co-staining (n = 6) demonstrated PD-mediated: Significant upregulation of αSMA (α-SMA: PD vs. Sham PD, p < 0.05; PD vs. Con, p < 0.01; ANOVA) (Fig. 3A and B); Enhanced EPCs recruitment (CD34: PD vs. Sham PD, p < 0.05; PD vs. Con, p < 0.01; Kruskal–Wallis test) (CD133: PD vs. Sham PD, p < 0.05; PD vs. Con, p < 0.01; ANOVA) (Fig. 3C and D); The PD group exhibited a significant increase in CD31+ endothelial cell density, whereas the Sham PD group demonstrated an intermediate level of CD31 expression that did not reach statistical significance (CD31: PD vs. Sham PD, p > 0.05; PD vs. Con, p < 0.05; ANOVA) (Fig. 3A and B). PD enhances both angiogenesis and recruits EPCs at wounds. A Wound sections were double-labelled for CD31 (red) and α-SMA (green), DAPI (blue); B Semi-quantitative analysis of immunostaining demonstrated significant upregulation of αSMA + blood vessels in the PD group (PD vs. Sham PD, p < 0.05; PD vs. Con, p < 0.01; ANOVA), increased CD31 + endothelial cell density (PD vs. Con, p < 0.05; ANOVA) and the Sham PD group showed intermediate CD31 expression (PD vs. Sham PD, p > 0.05; PD vs. Con, p > 0.05; ANOVA). C Wound sections were double-labelled for CD34 (red) and CD133 (green), DAPI (blue); Scale bar 75 μm; D Semi-quantitative measurement of immunofluorescence revealed that PD Enhances CD34 + and CD133 + endothelial progenitor cell recruitment (CD34: PD vs. Sham PD, p < 0.05; PD vs. Con, p < 0.01; Kruskal–Wallis test) (CD133: PD vs. Sham PD, p < 0.05; PD vs. Con, p < 0.05; ANOVA). Data were measured as means (standard deviations), *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, n = 6 SDF-1/CXCR4 and OPN signaling activation Semi-quantitative western blotting and immunofluorescence revealed: Increase in SDF-1 expression (SDF-1: PD vs. Sham PD, IF: p < 0.001, WB: p < 0.05; PD vs. Con, IF: p < 0.001, WB: p < 0.01; ANOVA) (Fig. 4A and C–E); Elevation in CXCR4 receptor levels (CXCR4: PD vs. Sham PD, IF: p < 0.0001, WB: p < 0.01; PD vs. Con, IF: p < 0.001, WB: p < 0.001; ANOVA) (Fig. 4B and C–E); Significant OPN upregulation (OPN: PD vs. Sham PD, IF: p < 0.0001, WB: p < 0.05; PD vs. Con, IF: p < 0.0001, WB: p < 0.05; ANOVA) (Fig. 5). PD mediated neovascularization through the SDF-1/CXCR4 pathway. A and B Immunofluorescence staining images of SDF-1 and CXCR4 from wound sections of three groups on day 15; Scale bar 75 μm; C Western blotting results of SDF-1 and CXCR4 from the left calf muscles on day 15; D and E Respective results of semi-quantitative immunofluorescence and western blotting revealed: increase in SDF-1 expression (PD vs. Sham PD, IF: p < 0.001, WB: p < 0.05; PD vs. Con, IF: p < 0.001, WB: p < 0.01; ANOVA); elevation in CXCR4 receptor levels (PD vs. Sham PD, IF: p < 0.0001, WB: p < 0.01; PD vs. Con, IF: p < 0.001, WB: p < 0.001; ANOVA); Data were measured as means (standard deviations), *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, n = 6 PD enhances lower extremity wound healing through OPN-mediated mechanisms. A Immunofluorescence staining images of OPN from wound sections of three groups on day 15; Scale bar 75 μm; B Western blotting results of OPN from the left calf muscles on day 15; C and D Results of semi-quantitative immunofluorescence staining and western blotting revealed: elevation in OPN expression (PD vs. Sham PD, IF: p < 0.0001, WB: p < 0.05; PD vs. Con, IF: p < 0.0001, WB: p < 0.05; ANOVA); Data were measured as means (standard deviations), *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, n = 6 Macrophage polarization via ERK1/2 phosphorylation Increase in pERK1/2 activation (pERK1/2: PD vs. Sham PD and PD vs. Con, IF: p < 0.0001; WB: p < 0.001; ANOVA) (Fig. 6B–E); Reduced M1 amount (iNOS: PD vs. Sham PD, p < 0.001; PD vs. Con, p < 0.0001; ANOVA) (Fig. 6F and G); Enhanced M2 polarization (CD206: PD vs. Sham PD, p < 0.01; PD vs. Con, p < 0.01; ANOVA). (Fig. 6F and G); No significant differences in total ERK1/2 expression were observed (ERK1/2: PD vs. Sham PD, IF: p = 0.99, WB: p = 0.6; PD vs. Con, IF: p = 0.99, WB: p = 0.99; Con vs. Sham PD, IF: p = 0.99, WB: p = 0.63; ANOVA) (Fig. 6A, C–E). PD enhances wound healing through ERK1/2 phosphorylated to accelerate M2 macrophage polarization to regulate the procedure of local inflammatory response. A and B Immunofluorescence staining images of ERK1/2 and pERK1/2 from wound sections of three groups on day 15; Scale bar 75 μm; C Western blotting results of ERK1/2 and pERK1/2 from the left calf muscles on day 15; D and E Respective results of semi-quantitative immunofluorescence and western blotting showed: Increase in pERK1/2 activation (PD vs. Sham PD, IF: p < 0.0001, WB: p < 0.001; PD vs. Con, IF: p < 0.0001, WB: p < 0.001; ANOVA) and no significant differences in total ERK1/2 expression (PD vs. Sham PD, IF: p = 0.99, WB: p = 0.6; PD vs. Con, IF: p = 0.99, WB: p = 0.99; Con vs. Sham PD, IF: p = 0.99, WB: p = 0.63; ANOVA); F Immunofluorescence staining images of M1 and M2 macrophages from wound sections of three groups on day 15, wound sections were double-labelled for iNOS (red) and CD206 (green), DAPI (blue); Scale bar 75 μm; G Semi-quantitative immunofluorescence showed: a higher proportion of M2 macrophages (CD206 +) and a reduced number of M1 macrophages (iNOS +) in the PD group, supporting the role of PD in modulating macrophage polarization(PD vs. Sham PD, iNOS: p < 0.001, CD206: p < 0.01; PD vs. Con, iNOS: p < 0.0001, CD206: p < 0.01; ANOVA); Data were measured as means (standard deviations), *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, n = 6 Discussion Ilizarov introduced the groundbreaking “tension-stress principle”, then introduced the principle of distraction osteogenesis (DO) [6], subsequently developing bone transport technology. Notably, this technique was observed to stimulate robust neovascularization and tissue regeneration in the peri-migration region, laying the foundation for the development of distraction histogenesis (DH) theory and TTT. Clinicians have increasingly adopted TTT for treating diabetic foot and lower extremity ulcerative diseases, achieving clinically satisfactory outcomes [3, 5, 19]. However, this procedure involves osteotomy techniques that present several limitations: surgical trauma, technical complexity, high costs, considerable patient discomfort during bone transport, potential postoperative infectious complications. To address these shortcomings, researchers have proposed modifications to the osteotomy morphology and surgical approach [20–23]. Several studies have demonstrated that periosteal distraction (PD) stimulates osteogenesis in animal models. For instance, PD of the mandible [12] and calvaria [13] in rabbits induced significant new bone formation. Similarly, experiments involving PD stimulation in rat skulls confirmed robust osteogenic responses [14, 15]. Given that PD induces localized bone regeneration, our team hypothesized that this technique might also promote wound healing in distant sites, consistent with the principles of DH theory. Supporting this concept, preliminary clinical studies have reported favorable outcomes following tibial periosteal distraction in patients with diabetic foot ulcers [16, 17]. A recent comparative study has evaluated TTT versus PD and found no significant difference in therapeutic efficacy between the two techniques [18]. However, the PD group demonstrated statistically significant reductions in operative duration, intraoperative blood loss, and postoperative pain scores compared to the TTT group. To optimize the surgical approach, our team developed a miniaturized periosteal distraction external fixation system. In this study, we established a skin defect model in which postoperative inflammatory responses initially led to wound swelling and a transient increase in wound area. To ensure experimental rigor, we adopted the methodology of prior studies [8] standardizing the baseline wound measurement on postoperative day 3 to account for early inflammatory changes. SDF-1/CXCR4 signaling axis plays a pivotal role in diverse physiological and pathological processes, including tumor metastasis [24], hematopoietic stem cell homing [25], organ development [26], and angiogenesis [27]. In diabetic rat models, TTT significantly accelerates lower-extremity wound healing, concomitant with upregulated SDF-1 and CXCR4 expression at both mRNA and protein levels [28], further supporting this mechanism. Recent work by Qin et al. [11] has substantiated the HIF-1α/SDF-1/CXCR4 pathway as a key molecular mechanism underlying TTT-mediated ulcer healing. The SDF-1/CXCR4 axis plays a crucial role in EPCs recruitment and homing to diabetic foot wounds [8], a finding substantiated by our experimental results. Relative quantitative analysis revealed significantly elevated expression of EPCs markers CD34 and CD133 in the PD group compared to control groups. These findings align with recent work by Tian et al. [29] who demonstrated that TTT upregulates SDF-1 expression in fibroblasts, subsequently enhancing VEGF-A production and facilitating EPC mobilization to ulcer sites. Our immunofluorescence analysis demonstrated markedly increased expression of CD31 and αSMA in the PD group, demonstrated that PD enhances both angiogenesis and vascular maturation at wound sites. These observations correlate with improved microcirculation and accelerated wound healing rates. The consistency between our results and established literature confirms the stability of PD-mediated neovascularization through the SDF-1/CXCR4 pathway. CD31 expression in the Sham PD group exhibited an intermediate level between the control and PD groups, though these differences did not reach statistical significance (p > 0.05). This pattern suggests that the surgical implantation of the U-ring device may have induced transient mechanical stimulation of the periosteum. However, in the absence of subsequent active distraction, such stimulation likely elicited only a partial and transient neovascularization response, as reflected by the moderate CD31 expression. We consider that PD not only enhances angiogenesis but also promotes vascular maturation, thereby contributing to a stable blood supply in the wound region. Furthermore, the 3-day latency period prior to the experimental endpoint may have allowed CD31-positive nascent vessels in the PD group to mature into αSMA-positive stable vessels. This transition could explain why CD31 expression in the PD group showed no significant difference from the Sham PD group, while αSMA expression was markedly increased. Other mechanisms, such as EPC recruitment or activation of alternative molecular pathways, may also play important roles in PD-mediated angiogenesis. Further studies using specific pathway inhibitors are planned to elucidate the underlying mechanisms. Osteopontin (OPN) plays critical roles in both inflammatory responses and tissue repair processes [30]. Furthermore, studies by Doyle et al. [31] and Meller et al. [32] have established OPN’s neuroprotective effects, showing its capacity to mitigate ischemic cell death in both in vitro and in vivo models. The therapeutic potential of OPN was further highlighted by Hu et al. [33] who reported that hyperbaric oxygen treatment exerts neuroprotective effects against cerebral ischemia through OPN upregulation. Recent clinical investigations have elucidated OPN’s mechanistic role in diabetic wound healing. Kong et al. [10] demonstrated that TTT in diabetic foot patients activated the Orai1/STIM1 pathway, thereby enhancing OPN expression and improving local blood flow and accelerating wound repair. In the present study, we observed significantly elevated OPN expression in the PD group compared to both Sham PD and control groups, as confirmed by immunofluorescence staining and western blot analysis. These findings provide compelling evidence that PD enhances lower extremity wound healing through OPN-mediated mechanisms. M1 macrophages driving inflammatory responses and pathogen clearance, while alternatively activated M2 macrophages facilitate tissue repair and regeneration [34–36]. Emerging evidence suggests that TTT promotes wound healing by inducing a phenotypic shift from pro-inflammatory M1 to pro-reparative M2 macrophages [8]. The ERK1/2 signaling pathway, a critical regulator of cellular processes including proliferation, differentiation, and migration, has been implicated in macrophage polarization. Recent studies indicate that phosphorylated ERK1/2 (pERK1/2) accelerates M1-to-M2 transition and enhances M2 polarization [8, 37, 38]. However, Ma et al. [39] reported that electrochemical stimulation of wounds promotes M1-to-M2 conversion independently of the ERK1/2 pathway, suggesting alternative regulatory mechanisms. In our study, PD significantly increased pERK1/2 expression compared to control groups. Immunofluorescence analysis further revealed a higher proportion of M2 macrophages (CD206 +) and a reduced number of M1 macrophages (iNOS +) in the PD group, supporting the role of PD in modulating macrophage polarization. These findings reveal that PD enhances wound healing through ERK1/2 phosphorylated to accelerate M2 macrophage polarization and regulate inflammatory response. TTT is supported by more extensive clinical evidence, with studies confirming the involvement of cytokines—including IL-6, TNF-α, and IL-10—in its therapeutic mechanisms [40, 41]. Furthermore, TTT has been shown to alleviate pain related to bone marrow edema through osteotomy and to activate the TCVs system [42, 43], thereby significantly enhancing the healing process. In contrast, PD offers a less invasive alternative with a comparatively simpler surgical procedure. Our group recognizes that PD serves as a supplementary technique rather than a replacement for TTT, the two approaches operate through not exactly same biological mechanisms. Currently, no comprehensive studies exist regarding the mechanism through which PD promotes wound healing in diabetic rats. Our work represents a preliminary investigation into these mechanisms. Further in‐depth research, including the application of specific channel blockers and exploration of TCVs-related pathways, will be conducted in subsequent studies. It has been suggested that combined antibiotic therapy (either systemic or local administration) and surgical intervention appears to be more effective than either treatment alone for diabetic foot [44–46]. This insight offers a promising direction for enhancing the efficacy of surgical management in diabetic foot care. This study has limitations. First, the clinical application of PD in the treatment of diabetic foot remains limited, with only a small number of patients having undergone this procedure to date. Second, our animal model cannot fully recapitulate the complex, chronic pathophysiology of human diabetic foot disease due to inherent species differences and the relatively short observation period. The exclusive use of male animals in this study, potential gender-related differences in wound healing responses were not assessed. Conclusion PD enhanced blood flow and regulated inflammatory response to accelerate diabetes foot ulcer healing. PD has not yet been broadly adopted in clinical practice. Moreover, its underlying mechanisms remain incompletely characterized. This study serves as a preliminary investigation into the potential mechanisms of PD to enhance wound healing in diabetic rats, laying the groundwork for future refinement of both TTT and PD techniques. Furthermore, it offers novel insights and proposes potential strategies for elucidating the biological mechanisms through which PD may facilitate tissue regeneration. Acknowledgements We are deeply grateful to the College of Forensic Medicine Hebei Medical University and the Animal Center of the Third Hospital of Hebei Medical University for providing essential experimental resources and support, which were indispensable to the completion of this study. Author contributions Z Zheng: Conceptualization, investigation, methodology, project administration, writing—original draft, writing—review & editing. H Guo: Conceptualization, Data curation, Investigation. S Wang: Conceptualization, investigation, methodology. X Bai: Data curation, project administration. Z Song: Funding acquisition, project administration, supervision. All authors read and approved the final manuscript. Funding This study received financial support from 2024 government-funded clinical medicine outstanding talent training project (ZF2024071) by Health Commission of Hebei Province and Hebei Provincial Department. Data availability All data generated or analyzed during this study are included in this article. Should any additional data or methodological details be required, they are available from the corresponding author upon reasonable request. Declarations Ethics approval and consent to participate All experimental procedures were approved by the Animal Research Ethics Committee of the Third Hospital of Hebei Medical University (Approval No. Z2024-004-2). Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement All data generated or analyzed during this study are included in this article. Should any additional data or methodological details be required, they are available from the corresponding author upon reasonable request.